Determinants of liver disease progression in children with chronic hepatitis C virus infection
Maria Pokorska-Śpiewak1, Barbara Kowalik-Mikołajewska, Małgorzata Aniszewska
1Maria Pokorska-Śpiewak MD, PhD, Department of Children's Infectious Diseases, Medical University of Warsaw, Wolska 37, 01-201 Warsaw, Poland, tel. +48 22 33 55 250, fax +48 22 33 55 379,
Insights
Chronic hepatitis C in children often shows mild liver damage, regardless of infection route. Higher BMI and longer infection duration predict more severe fibrosis, while aminotransferase levels correlate with liver inflammation and scarring.
Area of Science:
- Pediatric Hepatology
- Viral Hepatitis Research
- Clinical Gastroenterology
Background:
- Chronic hepatitis C (HCV) affects children, with vertical and horizontal transmission routes.
- Understanding liver disease progression in pediatric HCV is crucial for long-term outcomes.
Purpose of the Study:
- To analyze histopathological features of liver disease in children with chronic HCV.
- To identify determinants of liver disease progression, including necroinflammation and fibrosis.
Main Methods:
- Histopathological evaluation using Knodell's modified system in 42 treatment-naïve children.
- Linear regression analyses to identify predictors of necroinflammation and fibrosis.
Main Results:
- Most children exhibited mild necroinflammation and fibrosis, irrespective of transmission mode.
- Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels correlated with necroinflammation and fibrosis.
- Increased duration of infection and higher BMI z-score were independent predictors of more severe fibrosis.
Conclusions:
- Pediatric chronic HCV generally presents with mild liver changes over time.
- Fibrosis progression is time-dependent; vertically infected children may develop it earlier.
- Aminotransferase levels, infection duration, and BMI are key factors influencing liver disease severity in pediatric HCV.
Abstract:
Histopathological features and determinants of liver disease progression were analyzed in 42 treatment-naïve children (mean age: 10.7 ±3.7) with chronic hepatitis C (14/42 infected vertically and 26/42 horizontally). Histopathological evaluation was performed according to Knodell's modified system. Predictors of necroinflammation and fibrosis were identified using linear regression analyses. Most children presented with mild necroinflammation and fibrosis (mean grade 4.3 ±2.7, mean staging 1.2 ±0.8), irrespective of the mode of transmission. Vertically infected children were younger than those infected horizontally (8.6 ±2.5 vs. 11.5 ±3.7 years, p = 0.02). Alanine and aspartate aminotransferase (ALT and AST) levels were associated with necroinflammation (p = 0.003 and p = 0.01 for ALT and AST, respectively) and fibrosis (p = 0.01 and p = 0.04, respectively). Other positive independent predictors of fibrosis included duration of infection (p = 0.03) and body mass index (BMI) z-score (p = 0.03). Children with chronic hepatitis C presented with mild liver changes over a decade after the infection, irrespective of the mode of transmission. Since fibrosis is a time-dependent process, progression of the liver disease in vertically infected children may occur at a younger age compared to patients infected horizontally. Aminotransferase levels were associated with necroinflammation and fibrosis. Longer duration of infection and a higher BMI z-score were associated with more severe fibrosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatitis
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics in Pediatric Patients: Drug Metabolism


